{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:56:29Z","timestamp":1789563389977,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.pnpbp.2006.09.010","type":"journal-article","created":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T11:29:34Z","timestamp":1161775774000},"page":"370-372","source":"Crossref","is-referenced-by-count":76,"title":["High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania"],"prefix":"10.1016","volume":"31","author":[{"given":"Tiao-Lai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Chen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.09.010_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.metabol.2004.11.012","article-title":"High-sensitivity C-reactive protein is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients","volume":"54","author":"Anan","year":"2005","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3999(97)00139-6","article-title":"Acute phase protein in major depression","volume":"43","author":"Berk","year":"1997","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1034\/j.1600-0447.2002.0_435.x","article-title":"Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation","volume":"105","author":"Cassidy","year":"2002","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.psy.0000138132.66332.85","article-title":"Relationship between depression and C-reactive protein in a screening population","volume":"66","author":"Douglas","year":"2004","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib5","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/01.CIR.0000164203.54111.AE","article-title":"Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"111","author":"Empana","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib6","series-title":"User's Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV)","author":"Fisrt","year":"1997"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"Development of a rating scales for primary depressive illness","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-0327(97)00180-8","article-title":"Positive and negative acute phase proteins in affective subtypes","volume":"49","author":"Hornig","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib10","first-page":"509","article-title":"Lower serum albumin levels in patients with mood disorders","volume":"25","author":"Huang","year":"2002","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-2423(04)39003-7","article-title":"Cholesterol and lipids in depression: stress, hypothalamo\u2013pituitary\u2013adrenocortical axis and inflammation\/immunity","volume":"39","author":"Huang","year":"2005","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S1474-4422(05)70099-5","article-title":"Relation of C-reactive protein to stroke, cognitive disorders, and depression in general population: systemic review and metaanalysis","volume":"4","author":"Kuo","year":"2005","journal-title":"Lancet Neuro"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/appi.ajp.161.8.1499","article-title":"C-reactive protein and serotonin syndrome","volume":"161","author":"LeDoux","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00380962","article-title":"Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders","volume":"235","author":"Legros","year":"1985","journal-title":"Eur Arch Psychiatr Neurol Sci"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/appi.ajp.161.2.271","article-title":"The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes","volume":"161","author":"Lespernce","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0447.1991.tb03163.x","article-title":"Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1\u03b2 and soluble interleukin-2 receptor production","volume":"84","author":"Maes","year":"1991","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0278-5846(92)90056-K","article-title":"Disturbances in acute phase proteins during melancholia: additional evidence for the presence of inflammatory process during that illness","volume":"16","author":"Maes","year":"1992","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0327(94)00106-J","article-title":"Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activity","volume":"34","author":"Maes","year":"1995","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","article-title":"Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs","volume":"66","author":"Maes","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0327(99)00011-7","article-title":"Lower serum zinc in major depression in relation to changes in serum acute phase proteins","volume":"56","author":"Maes","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1192\/bjp.bp.105.011015","article-title":"Antidepressant therapy and C-reactive protein levels","volume":"188","author":"O'Brien","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application for C-reactive protein for vascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-3083.1995.tb03604.x","article-title":"Cytokine production and serum proteins in depression","volume":"41","author":"Seidel","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","article-title":"Indicators of immune activation in major depression","volume":"64","author":"Sluzewska","year":"1996","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0165-0327(94)90135-X","article-title":"Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls","volume":"30","author":"Song","year":"1994","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-0327(90)90088-P","article-title":"Albumin decrement in depression and cholesterol decrement in mania","volume":"19","author":"Swartz","year":"1990","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/hup.390","article-title":"Serological observations in patients suffering from acute manic episodes","volume":"17","author":"Wadee","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.09.010_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"153","author":"Young","year":"1978","journal-title":"Br J Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606003502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T18:50:27Z","timestamp":1547232627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606003502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0278584606003502"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.09.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}